Related references
Note: Only part of the references are listed.Vascular cognitive impairment, dementia, aging and energy demand. A vicious cycle
A. Popa-Wagner et al.
JOURNAL OF NEURAL TRANSMISSION (2015)
Incretin-based therapies: can we achieve glycemic control and cardioprotection?
Franca S. Angeli et al.
JOURNAL OF ENDOCRINOLOGY (2014)
Central effects of GLP-1: new opportunities for treatments of neurodegenerative diseases
Christian Hoelscher
JOURNAL OF ENDOCRINOLOGY (2014)
Influence of GLP-1 on Myocardial Glucose Metabolism in Healthy Men during Normo- or Hypoglycemia
Michael Gejl et al.
PLOS ONE (2014)
Central glucagon-like peptide 1 receptor-induced anorexia requires glucose metabolism-mediated suppression of AMPK and is impaired by central fructose
Melissa A. Burmeister et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2013)
GLP-1 Receptor Activation Indirectly Reduces Hepatic Lipid Accumulation But Does Not Attenuate Development of Atherosclerosis in Diabetic Male ApoE(-/-) Mice
Naim Panjwani et al.
ENDOCRINOLOGY (2013)
The Glucagon-Like Peptide-1 Receptor-or Not?
Charles Pyke et al.
ENDOCRINOLOGY (2013)
ROS and Brain Diseases: The Good, the Bad, and the Ugly
Aurel Popa-Wagner et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2013)
Sugar for the brain: the role of glucose in physiological and pathological brain function
Philipp Mergenthaler et al.
TRENDS IN NEUROSCIENCES (2013)
Exenatide promotes cognitive enhancement and positive brain metabolic changes in PS1-KI mice but has no effects in 3xTg-AD animals
M. Bomba et al.
CELL DEATH & DISEASE (2013)
Glucagon-like peptide-1 receptor activation reduces ischaemic brain damage following stroke in Type 2 diabetic rats
Vladimer Darsalia et al.
CLINICAL SCIENCE (2012)
Direct Control of Brown Adipose Tissue Thermogenesis by Central Nervous System Glucagon-Like Peptide-1 Receptor Signaling
Sarah H. Lockie et al.
DIABETES (2012)
Glucagon-like peptide-1 decreases intracerebral glucose content by activating hexokinase and changing glucose clearance during hyperglycemia
Michael Gejl et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2012)
Updated energy budgets for neural computation in the neocortex and cerebellum
Clare Howarth et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2012)
Exenatide Alters Myocardial Glucose Transport and Uptake Depending on Insulin Resistance and Increases Myocardial Blood Flow in Patients with Type 2 Diabetes
M. Gejl et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Effects of acute and chronic hyperglycemia on the neurochemical profiles in the rat brain with streptozotocin-induced diabetes detected using in vivo1H MR spectroscopy at 9.4 T
Wen-Tung Wang et al.
JOURNAL OF NEUROCHEMISTRY (2012)
AMPK: a nutrient and energy sensor that maintains energy homeostasis
D. Grahame Hardie et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Effects of Fluctuating Glucose Levels on Neuronal Cells In Vitro
Vincenzo C. Russo et al.
NEUROCHEMICAL RESEARCH (2012)
Neuronal and intracellular signaling pathways mediating GLP-1 energy balance and glycemic effects
Matthew R. Hayes
PHYSIOLOGY & BEHAVIOR (2012)
Insulin in the brain: There and back again
William A. Banks et al.
PHARMACOLOGY & THERAPEUTICS (2012)
Brain Imaging in Alzheimer Disease
Keith A. Johnson et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Neuroprotective properties of GLP-1: theoretical and practical applications
Jens Juul Holst et al.
CURRENT MEDICAL RESEARCH AND OPINION (2011)
Effects of Insulin on Brain Glucose Metabolism in Impaired Glucose Tolerance
Jussi Hirvonen et al.
DIABETES (2011)
Incretin Effects on β-cell Function, Replication, and Mass The human perspective
Alan J. Garber
DIABETES CARE (2011)
Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down?
M. A. Nauck et al.
DIABETOLOGIA (2011)
Chronic mild cerebrovascular dysfunction as a cause for Alzheimer's disease?
Christian Humpel
EXPERIMENTAL GERONTOLOGY (2011)
Targeting amyloid-beta by glucagon-like peptide-1 (GLP-1) in Alzheimer's disease and diabetes
Ann Mosegaard Bak et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2011)
Is the GLP-1 system a viable therapeutic target for weight reduction?
Jenny Tong et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2011)
Insulin and the brain
Zvi Laron
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2011)
Glycaemic variability and complications in patients with diabetes mellitus: evidence from a systematic review of the literature
L. Nalysnyk et al.
DIABETES OBESITY & METABOLISM (2010)
Glucose Variability; Does It Matter?
Sarah E. Siegelaar et al.
ENDOCRINE REVIEWS (2010)
Glucagon-like peptide-1 protects NSC-34 motor neurons against glucosamine through Epac-mediated glucose uptake enhancement
Jung-Geun Lim et al.
NEUROSCIENCE LETTERS (2010)
Modern-Day Clinical Course of Type 1 Diabetes Mellitus After 30 Years' Duration
ARCHIVES OF INTERNAL MEDICINE (2009)
Emerging cardiovascular actions of the incretin hormone glucagon-like peptide-1: potential therapeutic benefits beyond glycaemic control?
David J. Grieve et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
No increased risk of hypoglycaemic episodes during 48 h of subcutaneous glucagon-like-peptide-1 administration in fasting healthy subjects
Susanne Lerche et al.
CLINICAL ENDOCRINOLOGY (2009)
Central nervous insulin resistance: a promising target in the treatment of metabolic and cognitive disorders?
M. Hallschmid et al.
DIABETOLOGIA (2009)
Uncontrolled diabetes increases the risk of Alzheimer's disease: a population-based cohort study
W. L. Xu et al.
DIABETOLOGIA (2009)
Vildagliptin Enhances Islet Responsiveness to Both Hyper- and Hypoglycemia in Patients with Type 2 Diabetes
Bo Ahren et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Direct Control of Peripheral Lipid Deposition by CNS GLP-1 Receptor Signaling Is Mediated by the Sympathetic Nervous System and Blunted in Diet-Induced Obesity
Ruben Nogueiras et al.
JOURNAL OF NEUROSCIENCE (2009)
Receptors for the incretin glucagon-like peptide-1 are expressed on neurons in the central nervous system
Alison Hamilton et al.
NEUROREPORT (2009)
ACUTE TRYPTOPHAN DEPLETION IN RATS ALTERS THE RELATIONSHIP BETWEEN CEREBRAL BLOOD FLOW AND GLUCOSE METABOLISM INDEPENDENT OF CENTRAL SEROTONIN
E. L. Van Donkelaar et al.
NEUROSCIENCE (2009)
Intensive versus Conventional Glucose Control in Critically Ill Patients
S. Finfer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism
Yazhou Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Brain glucagon-like peptide-1 regulates arterial blood flow, heart rate, and insulin sensitivity
Cendrine Cabou et al.
DIABETES (2008)
Role of central nervous system glueagon-like peptide-1 reeeptors in enterie glueose sensing
Claude Knauf et al.
DIABETES (2008)
Arcuate glucagon-like peptide 1 receptors regulate glucose homeostasis but not food intake
Darleen A. Sandoval et al.
DIABETES (2008)
10-year follow-up of intensive glucose control in type 2 diabetes
Rury R. Holman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Glucagon-like peptide-1 inhibits blood-brain glucose transfer in humans
Susanne Lerche et al.
DIABETES (2008)
The physiology of glucagon-like peptide 1
Jens Juul Holst
PHYSIOLOGICAL REVIEWS (2007)
An input function estimation method for FDG-PET human brain studies
Hongbin Guo et al.
NUCLEAR MEDICINE AND BIOLOGY (2007)
Biology of incretins: GLP-1 and GIP
Laurie L. Baggio et al.
GASTROENTEROLOGY (2007)
GLP-1 receptor expression in human tumors and human normal tissues:: Potential for in vivo targeting
Meike Koerner et al.
JOURNAL OF NUCLEAR MEDICINE (2007)
Evidence of GLP-1-mediated neuroprotection in an animal model of pyridoxine-induced peripheral sensory neuropathy
TracyAnn Perry et al.
EXPERIMENTAL NEUROLOGY (2007)
Mitochondria and neuronal activity
Oliver Kann et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
The role of gut hormones in glucose homeostasis
Daniel J. Drucker
JOURNAL OF CLINICAL INVESTIGATION (2007)
Mechanisms linking obesity to insulin resistance and type 2 diabetes
Steven E. Kahn et al.
NATURE (2006)
Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure
George G. Sokos et al.
JOURNAL OF CARDIAC FAILURE (2006)
Attenuation of insulin-evoked responses in brain networks controlling appetite and reward in insulin resistance - The cerebral basis for impaired control of food intake in metabolic syndrome?
Karen Anthony et al.
DIABETES (2006)
Insulin signaling in the central nervous system: Learning to survive
Lars P. van der Heide et al.
PROGRESS IN NEUROBIOLOGY (2006)
Energy expenditure by intravenous administration of glucagon-like peptide-1 mediated by the lower brainstem and sympathoadrenal system
T Osaka et al.
PEPTIDES (2005)
Aggregation of vascular risk factors and risk of incident Alzheimer disease
JA Luchsinger et al.
NEUROLOGY (2005)
How palatable food disrupts appetite regulation
C Erlanson-Albertsson
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2005)
Human cerebral blood flow and metabolism in acute insulin-induced hypoglycemia
RP Kennan et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2005)
Glucagon-like peptide 1(GLP-1) in biology and pathology
JJ Meier et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2005)
The expression of GLP-1 receptor mRNA and protein allows the effect of GLP-1 on glucose metabolism in the human hypothalamus and brainstem
E Alvarez et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Neurobarrier coupling in the brain: a partner of neurovascular and neurometabolic coupling?
L Leybaert
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2005)
Cerebral dysfunction in type 1 diabetes: effects of insulin, vascular risk factors and blood-glucose levels
AMA Brands et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Cerebral glucose metabolism in diabetes mellitus
AL McCall
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Secretion, degradation, and elimination of glucagon-like peptide 1 and gastric inhibitory polypeptide in patients with chronic renal insufficiency and healthy control subjects
JJ Meier et al.
DIABETES (2004)
Effect of intravenous infusion of exenatide (synthetic exendin-4) on glucose-dependent insulin secretion and counterregulation during hypoglycemia
KB Degn et al.
DIABETES (2004)
Glucagon-like peptide: The time is near
A Huang et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2004)
Glucagon-like peptide-1: Regulation of insulin secretion and therapeutic potential
J Gromada et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2004)
Physiology of GLP-1 - Lessons from glucoincretin receptor knockout mice
B Thorens
HORMONE AND METABOLIC RESEARCH (2004)
On the physiology of GIP and GLP-1
JJ Holst
HORMONE AND METABOLIC RESEARCH (2004)
GLP-1 and extra-islet effects
B Ahrén
HORMONE AND METABOLIC RESEARCH (2004)
Glucagon-like peptide-1 receptor is involved in learning and neuroprotection
MJ During et al.
NATURE MEDICINE (2003)
Entry of exendin-4 into brain is rapid but may be limited at high doses
AJ Kastin et al.
INTERNATIONAL JOURNAL OF OBESITY (2003)
The role of insulin in human brain glucose metabolism -: An 18fluoro-deoxyglucose positron emission tomography study
EM Bingham et al.
DIABETES (2002)
Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier
AJ Kastin et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2002)
A novel neutrotrophic property of glucagon-like peptide 1: A promoter of nerve growth factor-mediated differentiation in PC12 cells
T Perry et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
The effect of insulin on in vivo cerebral glucose concentrations and rates of glucose transport/metabolism in humans
ER Seaquist et al.
DIABETES (2001)
Mortality and causes of death in the WHO multinational study of vascular disease in diabetes
NJ Morrish et al.
DIABETOLOGIA (2001)
Share Paper
